Centre for Brain and Mind, Department of Physiology & Pharmacology, Schulich School of Medicine and Dentistry, The University of Western Ontario, Medical Sciences Building, Room 216, 1151 Richmond Street North, London, Ontario N6A 5C1, Canada.
Hear Res. 2010 Aug;267(1-2):119-36. doi: 10.1016/j.heares.2010.04.003. Epub 2010 Apr 27.
The monoclonal antibody SMI-32 was used to characterize and distinguish individual areas of cat auditory cortex. SMI-32 labels non-phosphorylated epitopes on the high- and medium-molecular weight subunits of neurofilament proteins in cortical pyramidal cells and dendritic trees with the most robust immunoreactivity in layers III and V. Auditory areas with unique patterns of immunoreactivity included: primary auditory cortex (AI), second auditory cortex (AII), dorsal zone (DZ), posterior auditory field (PAF), ventral posterior auditory field (VPAF), ventral auditory field (VAF), temporal cortex (T), insular cortex (IN), anterior auditory field (AAF), and the auditory field of the anterior ectosylvian sulcus (fAES). Unique patterns of labeling intensity, soma shape, soma size, layers of immunoreactivity, laminar distribution of dendritic arbors, and labeled cell density were identified. Features that were consistent in all areas included: layers I and IV neurons are immunonegative; nearly all immunoreactive cells are pyramidal; and immunoreactive neurons are always present in layer V. To quantify the results, the numbers of labeled cells and dendrites, as well as cell diameter, were collected and used as tools for identifying and differentiating areas. Quantification of the labeling patterns also established profiles for ten auditory areas/layers and their degree of immunoreactivity. Areal borders delineated by SMI-32 were highly correlated with tonotopically-defined areal boundaries. Overall, SMI-32 immunoreactivity can delineate ten areas of cat auditory cortex and demarcate topographic borders. The ability to distinguish auditory areas with SMI-32 is valuable for the identification of auditory cerebral areas in electrophysiological, anatomical, and/or behavioral investigations.
单克隆抗体 SMI-32 用于对猫听觉皮层的各个区域进行特征分析和区分。SMI-32 标记皮质锥体神经元和树突上的神经丝蛋白的高分子量和中分子量亚基的非磷酸化表位,在 III 和 V 层具有最强的免疫反应性。具有独特免疫反应模式的听觉区域包括:初级听觉皮层 (AI)、次级听觉皮层 (AII)、背侧区 (DZ)、后听觉域 (PAF)、腹后听觉域 (VPAF)、腹侧听觉域 (VAF)、颞叶皮层 (T)、岛叶皮层 (IN)、前听觉域 (AAF) 和前外侧束沟的听觉域 (fAES)。鉴定出了独特的标记强度模式、胞体形状、胞体大小、免疫反应层、树突树分支的层状分布以及标记细胞密度。所有区域均具有相同特征:I 和 IV 层神经元免疫阴性;几乎所有免疫反应性细胞均为锥体;且 V 层中始终存在免疫反应性神经元。为了量化结果,收集了标记细胞和树突的数量以及细胞直径,并将其用作识别和区分区域的工具。对标记模式的定量分析还为十个听觉区域/层及其免疫反应性程度建立了图谱。SMI-32 标记的边界与音调定义的区域边界高度相关。总的来说,SMI-32 免疫反应性可以描绘猫听觉皮层的十个区域并划定拓扑边界。用 SMI-32 区分听觉区域的能力对于在电生理、解剖学和/或行为研究中识别听觉大脑区域非常有价值。